Cargando…

520. The Clinical Profile and Outcomes of Patients given Intravenous Colistin for Multidrug-Resistant Gram-negative Infections in a Philippine Tertiary Hospital

BACKGROUND: Colistimethate sodium (colistin) is used to treat multi-drug-resistant Gram-negative infections. We describe the profile and outcomes of patients given colistin in a tertiary level government hospital. METHODS: We performed a retrospective cross-sectional study of patients from the Phili...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Kingbherly L, Abad, Cybele Lara R
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6811272/ http://dx.doi.org/10.1093/ofid/ofz360.589

Ejemplares similares

Intravenous colistin in the treatment of multidrug-resistant gram-negative organism in tertiary hospital, Jazan, KSA
por: Ali, Eman M., et al.
Publicado: (2021)

495. Risk Factors of Carbapenem-Resistant Enterobacteriaceae (CRE) Infections Among Intensive Care Unit (ICU) Patients in a Tertiary Hospital in the Philippines
por: Torio, Roderick Oreal, et al.
Publicado: (2019)

1782. Guideline-Discordant Carbapenem Prescribing Policies at a Large, Urban Hospital in Manila, Philippines
por: Mitchell, Kaitlin, et al.
Publicado: (2018)

A descriptive retrospective study on HIV care cascade in a tertiary hospital in the Philippines
por: Nepomuceno, Marisse, et al.
Publicado: (2023)

482 Intrathecal Colistin Therapy to Treat Multidrug Resistant Gram Negative Central Nervous System Infection
por: Mukherjee, Dip Narayan
Publicado: (2014)

Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria
por: Witherell, Kaitlin S., et al.
Publicado: (2020)

Parenteral colistin for the treatment of severe infections by multidrug-resistant Gram-negative bacteria
por: Grion, C, et al.
Publicado: (2013)

Resensitizing multidrug-resistant Gram-negative bacteria to carbapenems and colistin using disulfiram
por: Chen, Chen, et al.
Publicado: (2023)

480. Molecular Characterization of Multidrug-Resistant Gram-Negative Pathogens in Three Tertiary Care Hospitals in Egypt
por: Kholy, Amani, et al.
Publicado: (2019)

Pharmacokinetics of colistin in patients with multidrug-resistant Gram-negative infections: A pilot study
por: Gautam, Vikas, et al.
Publicado: (2018)

Colistin Treatment for Multidrug-Resistant Gram-Negative Infections in Children: Caution Required for Nephrotoxicity
por: Ustundag, Gulnihan, et al.
Publicado: (2022)

2433. Evaluation of Meropenem (MEM) in Combination With Colistin (COL) Against Colistin-Resistant Extensively Drug-Resistant (XRD) Gram-Negative Bacteria
por: Singh, Nivedita, et al.
Publicado: (2018)

Procalcitonin as marker for bacterial coinfection among adult COVID-19 patients in a tertiary-care hospital in the Philippines
por: Pesebre, Angelie Lorraine, et al.
Publicado: (2022)

372. Prevalence of Urethral, Rectal, and Pharyngeal Gonorrhea and Chlamydia among Newly Diagnosed Filipino HIV Patients
por: Li, Kingbherly L, et al.
Publicado: (2019)

Efficacy and safety of colistin in the treatment of infections in the ICU caused by multidrug-resistant Gram-negative organisms
por: Pavleas, J, et al.
Publicado: (2006)

Catheter-related bloodstream infections in patients receiving hemodialysis in a single Philippine tertiary-care center
por: Mantaring, Dan Meynard, et al.
Publicado: (2023)

833. Characteristics and Utilization Patterns of Colistin Compared with Newer Agents in Gram-Negative Infections
por: Marcella, Stephen, et al.
Publicado: (2020)

Intravenous colistin in the treatment of sepsis from multiresistant Gram-negative bacilli in critically ill patients
por: Markou, Nikolaos, et al.
Publicado: (2003)

520. Development of Cefepime-taniborbactam MIC Antimicrobial Susceptibility Test (AST) for Enterobacterales and Pseudomonas aeruginosa on MicroScan Dried Gram-negative MIC Panels
por: Fernandez, Enrique J, et al.
Publicado: (2022)

Intravenous Colistin in the treatment of multidrug-resistant Acinetobacter in neonates
por: Al-lawama, Manar, et al.
Publicado: (2016)

730. Emerging patterns of multidrug resistance Gram negative bacterial infections and its clinical outcome at a tertiary medical center
por: Shetty, Shriya C, et al.
Publicado: (2023)

Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020)

Multidrug-resistant VAP before and during the COVID-19 pandemic among hospitalized patients in a tertiary private hospital
por: Aligui, Alec Ann Alissa F., et al.
Publicado: (2023)

976. Population Pharmacokinetic/Pharmacodynamic (PK/PD) Target Attainment Analysis of Intravenous Fosfomycin for Treatment of Multidrug-Resistant Gram-Negative Bacterial Infections
por: Wangchinda, Walaiporn, et al.
Publicado: (2023)

Multidrug-resistant ventilator-associated pneumonia (VAP) before and during the COVID-19 pandemic among hospitalized patients in a tertiary-care private hospital
por: Aligui, Alec Ann Alissa, et al.
Publicado: (2023)

Colistin in the treatment of infections from multiresistant Gram (-) bacilli
por: Markou, N, et al.
Publicado: (2002)

Feasibility of Neurapheresis™ as a Therapy for Multidrug Resistant Gram-negative Bacterial Meningitis
por: Ballard, Christi, et al.
Publicado: (2017)

Colistin monotherapy versus combination of colistin with a β-lactam or rifampicin for the treatment of serious infections in the ICU due to multidrug-resistant Gram-negative bacteria
por: Tsimogianni, A, et al.
Publicado: (2006)

Correction to: Ventilator-associated pneumonia caused by multidrug-resistant Gram-negative bacteria: understanding nebulization of aminoglycosides and colistin
por: Rouby, J. J., et al.
Publicado: (2020)

Synergistic Activity of Colistin in Combination With Resveratrol Against Colistin-Resistant Gram-Negative Pathogens
por: Cannatelli, Antonio, et al.
Publicado: (2018)

Comparative evaluation of the UMIC Colistine kit to assess MIC of colistin of gram-negative rods
por: Bardet, Lucie, et al.
Publicado: (2019)

Synergistic Activity of Colistin Combined With Auranofin Against Colistin-Resistant Gram-Negative Bacteria
por: Feng, Xiaoxuan, et al.
Publicado: (2021)

The Antibacterial Activity of Kaempferol Combined with Colistin against Colistin-Resistant Gram-Negative Bacteria
por: Zhou, Huijing, et al.
Publicado: (2022)

Synergistic Activity of Colistin in Combination with Clofoctol against Colistin Resistant Gram-Negative Pathogens
por: Collalto, Diletta, et al.
Publicado: (2023)

Inhaled colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria: A real-life experience in tertiary care hospitals in Saudi Arabia
por: Almangour, Thamer A., et al.
Publicado: (2020)

Multidrug-Resistant Gram-Negative bacilli Prosthetic Joint Infection: A Worrisome Scenario
por: Ribeiro, Taiana, et al.
Publicado: (2017)

2379. Multicenter Evaluation of Ceftazidime–Avibactam for Multidrug-Resistant Gram-Negative Bacterial Infections
por: Jorgensen, Sarah, et al.
Publicado: (2018)

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
por: Michalopoulos, Argyris, et al.
Publicado: (2005)

Aerosolized colistin for the treatment of nosocomial pneumonia due to multidrug-resistant Gram-negative bacteria in patients without cystic fibrosis
por: Mubareka, Samira, et al.
Publicado: (2005)

Naringenin restores colistin activation against colistin-resistant gram-negative bacteria in vitro and in vivo
por: Xu, Mengxin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rvpvsv5nd6c3dvp1eq1s7a8vc2